Commonwealth Bank of Australia (CBA), the nation’s largest lender, reported a slight rise in first-half profit, driven by economic recovery and a significant drop in loan impairment charges. The bank’s shares hit a record high following the announcement.
CBA’s cash net profit increased 2% to A$5.1 billion ($3.2 billion) for the six months ending December, slightly surpassing market expectations. The 23% decline in loan impairment charges provided a crucial boost, as profits would have remained nearly flat otherwise. Despite ongoing cost-of-living challenges, the bank noted a 15% drop in loan hardship cases, with most borrowers staying ahead on repayments.
CEO Matt Comyn anticipates Australia will begin an easing cycle in 2025, mirroring global economies. This, he believes, will alleviate financial pressure on households and bolster business confidence.
CBA declared its highest-ever interim dividend of A$2.25 per share, up from A$2.15 a year ago. The bank’s shares surged 1% to an intraday high of A$164.71, extending a strong rally that has made it Australia’s largest company by market capitalization. The broader market edged up 0.2%.
Despite the positive results, Citi analysts noted that the performance aligned with market expectations and did not necessarily justify the recent share price surge.
CBA, which controls a quarter of Australia’s A$2.2 trillion mortgage market, saw a 6% rise in costs as it invested in technology and AI infrastructure. The lender’s net interest margin improved by 2 basis points to 2.08%.
With rising wages and tax cuts boosting savings and spending, CBA remains optimistic about economic resilience despite inflationary pressures.


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Instagram Outage Disrupts Thousands of U.S. Users
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



